David A DO, MD
Internal Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 4
- 1 carrier
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. DO’s office at (408) 279-3599 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
California Medical Board record
Licence A78639 · Delinquent
Licence status: Delinquent · since 2002 · expires 2026-04-30 · St. George'S University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$795
Pharmacies billed $795 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 32) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
32 generic and 0 brand-name prescriptions · $795 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine-Naloxone | 30 | $794 | $26 |
Year by year
| 2024 | 32 | None | 0% (0) | 0% | $795 |
| 2023 | 30 | None | 0% (0) | 0% | $1,241 |
| 2022 | 12 | None | 0% (0) | 0% | $296 |
| 2021 | 16 | None | 0% (0) | None | $1,658 |
| 2020 | 18 | None | 0% (0) | 0% | $697 |
| 2019 | 11 | None | 0% (0) | None | $2,540 |
| 2014 | 45 | 29 | 38% (17) | None | $720 |
| 2013 | 167 | 49 | 12% (20) | 27% | $7,549 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Buprenorphine-Naloxone | 30 | $1,241 | $41 |
2022: 1 drug
| Buprenorphine-Naloxone | 11 | $225 | $20 |
2021: 1 drug
| Buprenorphine-Naloxone | 12 | $40 | $3 |
2020: 1 drug
| Buprenorphine-Naloxone | 11 | $601 | $55 |
Money from drug and device companies
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Indivior Inc. · Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior About Suboxone Buprenorphine and Naloxone Sublingual Film Ciii Safety and Use Information · 2019 | This clinician | $125 |
Professional record
- NPI
- 1801859459
- Licence
- CA A78639California A78639: Delinquent · expires 2026-04-30
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A786390
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 3650 Place De Louis, San Jose, CA, 95148
- NPI first listed
- 2006-04-06
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.